Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Goal and EQ504 Program in Immune-Mediated Illnesses – Slideshow

Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Goal and EQ504 Program in Immune-Mediated Illnesses – Slideshow